<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Pain Res</journal-id><journal-id journal-id-type="publisher-id">Journal of Pain Research</journal-id><journal-title-group><journal-title>Journal of pain research</journal-title></journal-title-group><issn pub-type="epub">1178-7090</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21197315</article-id><article-id pub-id-type="pmc">3004646</article-id><article-id pub-id-type="publisher-id">jpr-3-125</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Comparison of the effects of dietary factors in the management and prophylaxis of migraine</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zencirci</surname><given-names>Beyazit</given-names></name><xref ref-type="corresp" rid="c1-jpr-3-125"/></contrib><aff id="af1-jpr-3-125">Department of Anesthesiology and Reanimation, Medical Faculty of Sutcu Imam University, Kahramanmaras, Turkey</aff></contrib-group><author-notes><corresp id="c1-jpr-3-125">Correspondence: Beyazit Zencirci, M Akif Inan Mah. Alparslan Turkes Bulvari, Seyhan Apt. No: 209 D: 5 Merkez, 46050-Kahramanmaras, Turkey, Tel +90-344-2258300, Fax +90-344-2258303, Email <email>bzencirci@fastmail.fm</email></corresp></author-notes><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>23</day><month>7</month><year>2010</year></pub-date><volume>3</volume><fpage>125</fpage><lpage>130</lpage><history><date date-type="received"><day>22</day><month>7</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; 2010 Zencirci, publisher and licensee Dove Medical Press Ltd.</copyright-statement><license><license-p>This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Migraine is defined as a disorder characterized by intermittent headache episodes, accompanied with nausea, photophobia and/or phonophobia. Pharmacological therapy is in accordance with the severity of pain and may include acute, prophylactic and most commonly both approaches. The aim of the acute therapy is stopping or alleviating the attack or progression of the pain and, in case of a migraine attack that has started, lessening the pain. Preventive therapy aims to reduce attack frequency and severity. This study was designed to evaluate the effect of dietary factors in the management and prophylaxis of migraine in cases diagnosed as having migraine disorder according to the 2003-IHS criteria. Fifty consecutive Turkish patients (13 men, 37 women) with diagnosis of migraine were randomly divided into two groups for treatment protocols with the written approval of the ethics committee. The cases in the first group (K) were treated with metoprolol, vitamin B<sub>2</sub> (riboflavin), and naproxen sodium just at the aura or at the beginning of the attacks. The cases in the second group (D) were also supplied with a comprehensive dietary list arranged by our algology clinic in addition to the same medication protocol. There were no demographic differences between the cases (<italic>P</italic> &#x0003e; 0.05). VAS scores were lower in group D than group K (<italic>P</italic> &#x0003c; 0.01), and also the migraine attack frequencies and monthly amounts of analgesic consumed amounts were also statistically significantly less. It was concluded that beta-blocker and riboflavin therapy supplemented with a convenient diet with appropriate alternatives in patients with migraine disorder was associated with statistically significant decreases in headache frequency, intensity, duration and medication intake.</p></abstract><kwd-group><kwd>migraine</kwd><kwd>food intake</kwd><kwd>trigger</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Migraine is defined as a disorder characterized by intermittent headache episodes, accompanied with nausea, photophobia and/or phonophobia.<xref ref-type="bibr" rid="b1-jpr-3-125">1</xref> Migraine attacks seem to result from pathophysiological mechanisms activated by specific trigger factors. The recurrence of migraine attacks may depend either on a reduced threshold or on particularly strong or frequent trigger factors or both.<xref ref-type="bibr" rid="b2-jpr-3-125">2</xref> Biochemical research has provided evidence for certain physiologic characteristics in migraineurs, which have been proposed as predisposing factors for migraine. These include platelet serotonin (5-HT) metabolism, platelet activation, increased sensitivity to nitric oxide (NO) donors, reduced levels of metabolic enzymes, abnormal opiate receptor function, and electro-encephalographic (EEG) abnormalities.<xref ref-type="bibr" rid="b3-jpr-3-125">3</xref></p><p>Pharmacological therapy, in accordance with the severity of pain, may include acute or prophylactic and most commonly both approaches. Acute therapy is stopping or alleviating the attack or progression of the pain and, in case of a migraine attack that has started, attempts to lessen the pain. Preventive treatment is indicated when the attacks are long lasting, severe and disabling and do not respond to acute treatments.<xref ref-type="bibr" rid="b4-jpr-3-125">4</xref> Preventive therapy aims to reduce attack frequency and severity.<xref ref-type="bibr" rid="b5-jpr-3-125">5</xref> The preventive treatment for migraine includes beta-blockers, antidepressants, calcium channel antagonists, serotonin antagonists, non-steroid anti-inflammatory drugs (NSAIDs), riboflavin (vitamin B<sub>2</sub>) at high doses and anticonvulsant drugs.<xref ref-type="bibr" rid="b6-jpr-3-125">6</xref></p><p>An understanding of the aura and headache components of migraine provide a basis for the potential mechanisms of action of dietary triggers. Dietary migraine triggers may influence the pathophysiology of migraine at one or more phases of the migraine attack. They could affect the cerebral cortex, trigeminal nerve, brainstem trigeminal nuclei, thalamus, and brainstem or limbic pathways. The chemical trigger may stimulate neuroreceptors, cause release of neurotransmitters, or have a direct effect on neurons within the trigeminovascular migraine pathways.<xref ref-type="bibr" rid="b7-jpr-3-125">7</xref></p><p>We conducted our study on 50 patients who were diagnosed with migraine [according to the 2003-International Headache Society (IHS) criteria<xref ref-type="bibr" rid="b8-jpr-3-125">8</xref> (<xref ref-type="table" rid="t1-jpr-3-125">Table 1</xref>)]. In our research, we could not find any studies previously conducted with an extended diet list covering foodstuffs that are acknowledged to trigger migraine attacks. Thus, by completely removing some foodstuffs that we listed as triggering migraine headaches in various studies (having regard to dietary habits of Turkish society) from the daily diet lists of patients, we wanted to observe the effect on the consumption of analgesic medicines used for migraine headaches (recurrence and severity).</p></sec><sec sec-type="methods"><title>Method</title><p>With the written approval of the ethics committee, we started our study with 56 patients. However, 6 patients left the study or were ineligible for various reasons. Therefore 50 consecutive Turkish patients (13 men, 37 women) with diagnosis of migraine were randomly divided into 2 groups for treatment protocols. Cases with menstruational migraine were excluded from the study. Patients in each group were well informed about their diseases and the treatment modalities were applied.</p><p>Patients in the first group (Group K) were treated with metoprolol (120 mg/day), vitamin B<sub>2</sub> (riboflavin 600 mg, 3 times a day), and naproxen sodium (550 mg) just at the aura or at the beginning of the attacks.</p><p>In addition to being provided with the same medication protocol, patients in the second group (Group D) were also supplied with a comprehensive dietary list (<xref ref-type="table" rid="t2-jpr-3-125">Table 2</xref>) arranged by our algology clinic. Furthermore, patients were also informed about the visual analog scale (VAS) and keeping a daily pain diary (DPD). They were asked to record their headache VAS scores, attack frequencies and severities and also naproxen sodium consumption starting from the beginning of the therapy.</p><p>Patients were recalled for control examinations every 15 days and their data (with special attention to their DPD) were recorded throughout a year.</p><p>All data were collected in an Excel<sup>&#x000ae;</sup> spread sheet for documentation. For statistical analysis, SPSS 13.0<sup>&#x000ae;</sup> for Windows (LEAD Technologies Inc, USA, 2004) was used. The Mann-Whitney U test was used to compare the differences between demographic data of patients such as age, length and weight; and Chi square test was used to compare the difference between gender and migraine type. The Mann-Whitney U test was also used to compare the differences between monthly VAS, monthly number of attacks and monthly analgesic consumption of the two groups. Statistical significance was defined as <italic>P</italic> &#x0003c; 0.05.</p></sec><sec sec-type="results"><title>Results</title><p>There were no demographic differences between the cases (<italic>P</italic> &#x0003e; 0.05) (<xref ref-type="table" rid="t3-jpr-3-125">Table 3</xref>). VAS scores were lower in Group D than in Group K (<italic>P</italic> &#x0003c; 0.01), and the migraine attack frequencies and monthly analgesic consumption amounts were also significantly lower (<italic>P</italic> &#x0003c; 0.01) (<xref ref-type="table" rid="t4-jpr-3-125">Table 4</xref>).</p></sec><sec sec-type="discussion"><title>Discussion</title><p>The pharmacological treatment of migraine may be acute or preventive, and patients who experience frequent severe headache attacks often require both approaches. The contemporary guidelines include few prophylactic drugs under the recommendations of Group I on the basis of evidence, scientific effect and clinical assessment. They are: amitriptyline, atenolol, propranolol, flunarizine, and valproate sodium. Group II includes: nonsteroidal anti-inflammatory drugs, specifically naproxen and naproxen sodium as well as lornoxicam; antiepileptic drugs gabapentin, lamotrigine, topiramate; calcium channel blockers verapamil and cinnarizine; selective serotonin reuptake inhibitor fluoxetine; beta-blockers (metoprolol and nadolol); dihydroergotamine and vitamin B<sub>2</sub>.<xref ref-type="bibr" rid="b9-jpr-3-125">9</xref></p><p>How beta-blockers reduce attack frequency in migraneurs is not clear, although it is probably by acting on the central monoaminergic system and serotonin receptors. Not all of these drugs are effective, and those used in migraine prophylaxis include atenolol, metoprolol, nadolol and propranolol.<xref ref-type="bibr" rid="b10-jpr-3-125">10</xref>&#x02013;<xref ref-type="bibr" rid="b15-jpr-3-125">15</xref></p><p>Vitamin B<sub>2</sub> is a water-soluble essential precursor to flavin mononucleotides necessary for electron transport within the Krebs cycle. It is essential to normal production of ATP and thus for maintaining membrane stability and for all energy-related cellular functions.<xref ref-type="bibr" rid="b16-jpr-3-125">16</xref> A mitochondrial dysfunction causing impaired oxygen metabolism may play a role in migraine pathogenesis. Riboflavin at high doses (up to 400 mg) showed good effectiveness in preventing migraine attacks with a low rate of unwanted side effects, such as mild abdominal pain and diarrhea.<xref ref-type="bibr" rid="b17-jpr-3-125">17</xref></p><p>The role of dietary factors in provoking migraine attacks is of increased interest.<xref ref-type="bibr" rid="b18-jpr-3-125">18</xref>&#x02013;<xref ref-type="bibr" rid="b21-jpr-3-125">21</xref> The role of serotonin (5-HT) in migraine has intrigued investigators observing that the migraine attack is associated with an increased excretion of serotonin metabolites.<xref ref-type="bibr" rid="b22-jpr-3-125">22</xref> Serotonin released from hypersensitive platelets has been suggested as one of the precipitators of the vasoconstrictor phase of migraine. A reduction in platelet serotonin might thus have a beneficial effect.</p><p>Such a reduction could theoretically be achieved by a reduced dietary intake of serotonin and the serotonin precursor tryptophan (TRP).<xref ref-type="bibr" rid="b23-jpr-3-125">23</xref>,<xref ref-type="bibr" rid="b24-jpr-3-125">24</xref> A carbohydrate-rich meal, with subsequent insulin secretion, increases the availability of TRP to the brain and thereby also the serotonin synthesis in the brain.<xref ref-type="bibr" rid="b25-jpr-3-125">25</xref> TRP is the scarcest of the amino acids and constitutes on average only about 1/100th of the total amino acid content of proteins. The dietary intake of TRP and protein is usually considerably higher than the required amount. However, an increased serotonin level in the brain is probably helpful in alleviating migraine headache, since serotonin is known to be involved in the anti-nociceptive system.<xref ref-type="bibr" rid="b26-jpr-3-125">26</xref></p><p>A variety of amines have been implicated in the development of headache, most commonly tyramine (TYR), histamine (HIS), and beta-phenylethylamine (PEA).<xref ref-type="bibr" rid="b27-jpr-3-125">27</xref>&#x02013;<xref ref-type="bibr" rid="b28-jpr-3-125">28</xref> Cheeses, peanuts, meats, and alcohol are known to contain TYR, HIS, and PEA. Citrus fruits contain octopamine and synephrine. All of these foods has been implicated clinically to be causally related to headache activity.</p><p>One of the most commonly cited food triggers of headache is chocolate. Chocolate is especially rich in a variety of vasoactive amines including PEA, which crosses the blood&#x02013;brain barrier and effects cerebral blood flow. Headache may therefore be related to a different metabolism. Theobromine, a methylxanthine found in cocoa that is similar in chemical structure to caffeine may act as a headache trigger.<xref ref-type="bibr" rid="b29-jpr-3-125">29</xref></p><p>Many people believe that by avoiding some specific foods it is possible to reduce the frequency of migraine attacks. Putative allergic factors are often considered responsible for migraine attacks, whereas, only in rare cases, a specific food directly causes migraine. By contrast, fasting has been described to be a precipitating factor in 25% of children and in 40% of adults affected. Also, some foods are involved as precipitating factors in percentages varying from 10% to 45%, namely: chocolate, cheese, some fruits, citrus fruits, fatty foods and fried food.<xref ref-type="bibr" rid="b30-jpr-3-125">30</xref> <xref ref-type="table" rid="t5-jpr-3-125">Table 5</xref> lists potential food items that have been reported to trigger migraine headaches and the chemical constituent thought to be specifically involved in the mechanism of the attack.<xref ref-type="bibr" rid="b7-jpr-3-125">7</xref></p><p>Some dietary restriction studies have reported a decrease in headache after participation in an elimination diet.<xref ref-type="bibr" rid="b31-jpr-3-125">31</xref>,<xref ref-type="bibr" rid="b32-jpr-3-125">32</xref> In contrast some studies have found that dietary restriction does not significantly decrease headache<xref ref-type="bibr" rid="b33-jpr-3-125">33</xref> or that placebos are as likely to result in headache as challenge foods.<xref ref-type="bibr" rid="b34-jpr-3-125">34</xref></p><p>Peatfield<xref ref-type="bibr" rid="b35-jpr-3-125">35</xref> recorded 19% of patients reporting sensitivity to cheese, chocolate, or both, and 11% of patients sensitive to citrus fruits. The exact mechanism of these migraine attacks is unknown, although migraines are believed to be caused by a chemical reaction consisting of the release of serotonin from the intestinal wall, or by an enzymatic defect, and not by allergic reactions.</p><p>Peatfield studied 60 patients with migraine mean duration of migraines was 18 years for women and 22 years for men. When patients were put on an exclusion diet, in most cases, migraines disappeared by the fifth day. The mean number of foods causing symptoms was 10 per patient, the most frequent offenders being wheat, orange, egg, tea and coffee, chocolate and milk, beef, corn, cane sugar, and yeast, mushrooms, and peas. When offending foods were avoided, all patients improved. In fact, the number of headaches fell from 402 to 6 per month, with 85% of the subjects becoming headache free.<xref ref-type="bibr" rid="b35-jpr-3-125">35</xref></p><p>Elimination diets have been shown to be valuable in treating migraine. When 88 children with severe migraines were put on an oligoantigenic diet, 93% improved.<xref ref-type="bibr" rid="b31-jpr-3-125">31</xref> In another study of 17 patients who completed an elimination diet, migraine attacks were found to be most frequently caused by cow&#x02019;s milk (10 out of the 17). Other culprits included flour, eggs, cheese, pork, and artificial colors and preservatives.<xref ref-type="bibr" rid="b36-jpr-3-125">36</xref>,<xref ref-type="bibr" rid="b37-jpr-3-125">37</xref></p><p>In this study we tried to prepare a detailed and strict dietary program that avoided food that is believed to precipitate migraine attacks. In light of the previous studies on this subject patients can also be offered alternative food choices. We believe that avoiding stress is as effective as diet and prophylactic medications in the prevention of headache episodes. The findings of this study revealed decreased severity and frequency of headache episodes and less analgesic consumption in the group that was treated with the dietary list, verifying our hypothesis.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>It was determined that beta-blocker and riboflavin therapy supplied with an appropriate diet (with alternatives) was associated with statistically significant decreases in headache frequency, intensity, duration and medication intake. The prevention of headaches by attention to precipitating factors may be preferable to long-term prophylactic drug treatment with attending adverse reactions.</p><p>We once again ascertained in this study that diet is of great importance in migraine treatment. Throughout the course of treatment, we observed many positive effects of an appropriate diet list and its correct application on patients with migraine. We believe more positive results can be achieved if a diet list is attached to prescriptions.</p></sec><sec><title>Consent</title><p>Written informed consent was obtained from the patients for the publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p></sec></body><back><fn-group><fn><p><bold>Disclosure</bold></p><p>The author declares that he has no competing interests. BZ presented the case histories, performed case management, drafted the manuscript. The author read and approved the final manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-jpr-3-125"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robert</surname><given-names>GK</given-names></name></person-group><article-title>Diagnostic issues in migraine</article-title><source>Curr Pain Headache Rep</source><year>2001</year><volume>5</volume><issue>2</issue><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">11252153</pub-id></mixed-citation></ref><ref id="b2-jpr-3-125"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandrini</surname><given-names>G</given-names></name><name><surname>Cecchini</surname><given-names>AP</given-names></name><name><surname>Hristova</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Neurophysiology of migraine</article-title><source>J Headache Pain</source><year>2001</year><volume>2</volume><fpage>S67</fpage><lpage>S71</lpage></mixed-citation></ref><ref id="b3-jpr-3-125"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breslau</surname><given-names>N</given-names></name><name><surname>Rasmussen</surname><given-names>BK</given-names></name></person-group><article-title>The impact of migraine: Epidemiology, risk factors, and co-morbidities</article-title><source>Neurology</source><year>2001</year><volume>56</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11148226</pub-id></mixed-citation></ref><ref id="b4-jpr-3-125"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moschiano</surname><given-names>F</given-names></name><name><surname>Grazzi</surname><given-names>L</given-names></name><name><surname>D&#x02019;Amico</surname><given-names>D</given-names></name><etal/></person-group><article-title>Menstrual migraine</article-title><source>J Headache Pain</source><year>2001</year><volume>2</volume><fpage>117</fpage><lpage>119</lpage></mixed-citation></ref><ref id="b5-jpr-3-125"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silberstein</surname><given-names>SD</given-names></name><name><surname>Goadsby</surname><given-names>PJ</given-names></name></person-group><article-title>Migraine: preventive treatment</article-title><source>Cephalalgia</source><year>2002</year><volume>22</volume><issue>7</issue><fpage>491</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">12230591</pub-id></mixed-citation></ref><ref id="b6-jpr-3-125"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pini</surname><given-names>LA</given-names></name><name><surname>Lupo</surname><given-names>L</given-names></name></person-group><article-title>Anti-epileptic drugs in the preventive treatment of migraine headache: a brief review</article-title><source>J Headache Pain</source><year>2001</year><volume>2</volume><fpage>13</fpage><lpage>19</lpage></mixed-citation></ref><ref id="b7-jpr-3-125"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millichap</surname><given-names>JG</given-names></name><name><surname>Yee</surname><given-names>MM</given-names></name></person-group><article-title>The diet factor in pediatric and adolescent migraine</article-title><source>Pediatr Neurol</source><year>2003</year><volume>28</volume><issue>1</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12657413</pub-id></mixed-citation></ref><ref id="b8-jpr-3-125"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Headache Classification Subcommittee of the International Headache Society</collab></person-group><article-title>The international classification of headache disorders</article-title><source>Cephalalgia</source><year>2004</year><volume>24</volume><fpage>1</fpage><lpage>151</lpage></mixed-citation></ref><ref id="b9-jpr-3-125"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallai</surname><given-names>V</given-names></name><name><surname>Sarchielli</surname><given-names>P</given-names></name></person-group><article-title>Diagnostic and therapeutic guidelines for migraine. Italian Society for the Study of Headaches (SISC)</article-title><source>J Headache Pain</source><year>2001</year><volume>2</volume><fpage>125</fpage><lpage>129</lpage></mixed-citation></ref><ref id="b10-jpr-3-125"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f8;rgesen</surname><given-names>SE</given-names></name><name><surname>Nielsen</surname><given-names>JL</given-names></name><name><surname>M&#x000f8;ller</surname><given-names>CE</given-names></name></person-group><article-title>Prophylactic treatment of migraine with propranolol. A clinical trial</article-title><source>Acta Neurol Scand</source><year>1974</year><volume>50</volume><issue>5</issue><fpage>651</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">4611129</pub-id></mixed-citation></ref><ref id="b11-jpr-3-125"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>NT</given-names></name></person-group><article-title>Prophylaxis of migraine and mixed headache. A randomized controlled study</article-title><source>Headache</source><year>1981</year><volume>21</volume><issue>3</issue><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">7021472</pub-id></mixed-citation></ref><ref id="b12-jpr-3-125"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>PG</given-names></name><name><surname>Dahl</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Prophylactic treatment of classical and non-classical migraine with metoprolol: a comparison with placebo</article-title><source>Cephalalgia</source><year>1983</year><volume>3</volume><issue>4</issue><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">6640652</pub-id></mixed-citation></ref><ref id="b13-jpr-3-125"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olerud</surname><given-names>B</given-names></name><name><surname>Gustavsson</surname><given-names>CL</given-names></name><name><surname>Furberg</surname><given-names>B</given-names></name></person-group><article-title>Nadolol and propranolol in migraine management</article-title><source>Headache</source><year>1986</year><volume>26</volume><issue>10</issue><fpage>490</fpage><lpage>493</lpage><pub-id pub-id-type="pmid">3546194</pub-id></mixed-citation></ref><ref id="b14-jpr-3-125"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forssman</surname><given-names>B</given-names></name><name><surname>Lindblad</surname><given-names>CJ</given-names></name><name><surname>Zbornikova</surname><given-names>V</given-names></name></person-group><article-title>Atenolol for migraine prophylaxis</article-title><source>Headache</source><year>1983</year><volume>23</volume><issue>4</issue><fpage>188</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">6350226</pub-id></mixed-citation></ref><ref id="b15-jpr-3-125"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>RE</given-names><suffix>Sr</suffix></name><name><surname>Ryan</surname><given-names>RE</given-names><suffix>Jr</suffix></name><name><surname>Sudilovsky</surname><given-names>A</given-names></name></person-group><article-title>Nadolol: its use in the prophylactic treatment of migraine</article-title><source>Headache</source><year>1983</year><volume>23</volume><issue>1</issue><fpage>26</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">6131052</pub-id></mixed-citation></ref><ref id="b16-jpr-3-125"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>RW</given-names></name><name><surname>Taylor</surname><given-names>FR</given-names></name></person-group><article-title>&#x0201c;Natural&#x0201d; or alternative medications for migraine prevention</article-title><source>Headache</source><year>2006</year><volume>46</volume><issue>6</issue><fpage>1012</fpage><lpage>1018</lpage><pub-id pub-id-type="pmid">16732849</pub-id></mixed-citation></ref><ref id="b17-jpr-3-125"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenen</surname><given-names>J</given-names></name><name><surname>Jacquy</surname><given-names>J</given-names></name><name><surname>Lenaerts</surname><given-names>M</given-names></name></person-group><article-title>Effectiveness of high-dose riboflavin in migraine. A randomized controlled trial</article-title><source>Neurology</source><year>1998</year><volume>50</volume><issue>2</issue><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">9484373</pub-id></mixed-citation></ref><ref id="b18-jpr-3-125"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mediana</surname><given-names>JL</given-names></name><name><surname>Diamond</surname><given-names>S</given-names></name></person-group><article-title>Migraine and atopy</article-title><source>Headache</source><year>1976</year><volume>15</volume><issue>4</issue><fpage>271</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">1245408</pub-id></mixed-citation></ref><ref id="b19-jpr-3-125"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glover</surname><given-names>V</given-names></name><name><surname>Littlewood</surname><given-names>J</given-names></name><name><surname>Sandler</surname><given-names>M</given-names></name><etal/></person-group><article-title>Biochemical predisposition to dietary migraine: the role of phenolsulfotransferase</article-title><source>Headache</source><year>1983</year><volume>23</volume><issue>2</issue><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">6343297</pub-id></mixed-citation></ref><ref id="b20-jpr-3-125"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monro</surname><given-names>J</given-names></name><name><surname>Carini</surname><given-names>C</given-names></name><name><surname>Brostoff</surname><given-names>J</given-names></name></person-group><article-title>Migraine is a food-allergic disease</article-title><source>Lancet</source><year>1984</year><volume>2</volume><issue>8405</issue><fpage>719</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">6148473</pub-id></mixed-citation></ref><ref id="b21-jpr-3-125"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peatfield</surname><given-names>RC</given-names></name><name><surname>Glover</surname><given-names>V</given-names></name><name><surname>Littlewood</surname><given-names>JT</given-names></name><etal/></person-group><article-title>The prevalence of diet-induced migraine</article-title><source>Cephalalgia</source><year>1984</year><volume>4</volume><issue>3</issue><fpage>179</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">6498931</pub-id></mixed-citation></ref><ref id="b22-jpr-3-125"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sicuteri</surname><given-names>F</given-names></name><name><surname>Testi</surname><given-names>A</given-names></name><name><surname>Anselmi</surname><given-names>B</given-names></name></person-group><article-title>Biochemical investigations in headache: increase in the hydroxy-indole-acetic excretion during migraine attacks</article-title><source>Int Arch Allergy</source><year>1961</year><volume>19</volume><issue>1</issue><fpage>55</fpage><lpage>58</lpage></mixed-citation></ref><ref id="b23-jpr-3-125"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>M</given-names></name><name><surname>Hinterberger</surname><given-names>H</given-names></name><name><surname>Lance</surname><given-names>JW</given-names></name></person-group><article-title>Plasma serotonin in migraine and stress</article-title><source>Arch Neurol</source><year>1967</year><volume>16</volume><issue>5</issue><fpage>544</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">5297855</pub-id></mixed-citation></ref><ref id="b24-jpr-3-125"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilton</surname><given-names>BP</given-names></name><name><surname>Cumings</surname><given-names>JN</given-names></name></person-group><article-title>5-hydroxytryptamine levels and platelet aggregation responses in subjects with acute migraine headache</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1972</year><volume>35</volume><issue>4</issue><fpage>505</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">5049809</pub-id></mixed-citation></ref><ref id="b25-jpr-3-125"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernstrom</surname><given-names>JD</given-names></name></person-group><article-title>Dietary precursors and brain transmitter formation</article-title><source>Ann Rev Med</source><year>1981</year><volume>32</volume><fpage>413</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">6111981</pub-id></mixed-citation></ref><ref id="b26-jpr-3-125"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sicuteri</surname><given-names>F</given-names></name></person-group><article-title>Endorphins, opiate receptors and migraine headache</article-title><source>Headache</source><year>1978</year><volume>17</volume><issue>6</issue><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">202579</pub-id></mixed-citation></ref><ref id="b27-jpr-3-125"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCulloch</surname><given-names>J</given-names></name><name><surname>Harper</surname><given-names>AM</given-names></name></person-group><article-title>Phenylethylamine and cerebral blood flow: possible involvement of phenylethylamine in migraine</article-title><source>Neurol</source><year>1977</year><volume>27</volume><issue>9</issue><fpage>817</fpage><lpage>821</lpage></mixed-citation></ref><ref id="b28-jpr-3-125"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCulloch</surname><given-names>J</given-names></name><name><surname>Harper</surname><given-names>AM</given-names></name></person-group><article-title>Factors influencing the response of the cerebral circulation to phenylethylamine</article-title><source>Neurol</source><year>1979</year><volume>29</volume><issue>2</issue><fpage>201</fpage><lpage>207</lpage></mixed-citation></ref><ref id="b29-jpr-3-125"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarka</surname><given-names>SM</given-names></name></person-group><article-title>The toxicology of cocoa and methylaxantines: a review of the literature</article-title><source>Crit Rev Toxicol</source><year>1982</year><volume>9</volume><issue>4</issue><fpage>275</fpage><lpage>312</lpage><pub-id pub-id-type="pmid">6765610</pub-id></mixed-citation></ref><ref id="b30-jpr-3-125"><label>30.</label><mixed-citation publication-type="journal"><article-title>Prophylactic treatment of migraine</article-title><source>J Headache Pain</source><year>2001</year><volume>2</volume><fpage>147</fpage><lpage>161</lpage></mixed-citation></ref><ref id="b31-jpr-3-125"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>J</given-names></name><name><surname>Carter</surname><given-names>CM</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment</article-title><source>Lancet</source><year>1983</year><volume>2</volume><issue>8355</issue><fpage>865</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">6137694</pub-id></mixed-citation></ref><ref id="b32-jpr-3-125"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>LE</given-names></name><name><surname>Vaughn</surname><given-names>TR</given-names></name><name><surname>Waller</surname><given-names>SF</given-names></name></person-group><article-title>Food allergy and adult migraine, double-blind and mediator confirmation of an allergic etiology</article-title><source>Ann Allergy</source><year>1985</year><volume>55</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">4025956</pub-id></mixed-citation></ref><ref id="b33-jpr-3-125"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohlenberg</surname><given-names>RJ</given-names></name></person-group><article-title>Thyramine sensitivity in dietary migraine: a critical review</article-title><source>Headache</source><year>1982</year><volume>22</volume><issue>1</issue><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">17152742</pub-id></mixed-citation></ref><ref id="b34-jpr-3-125"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffett</surname><given-names>AM</given-names></name><name><surname>Swash</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>DF</given-names></name></person-group><article-title>Effect of chocolate in migraine: a double-blind study</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1974</year><volume>37</volume><issue>4</issue><fpage>445</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">4838915</pub-id></mixed-citation></ref><ref id="b35-jpr-3-125"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peatfield</surname><given-names>RC</given-names></name></person-group><article-title>Relationships between food, wine, and beer-precipitated migrainous headaches</article-title><source>Headache</source><year>1995</year><volume>35</volume><issue>6</issue><fpage>355</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">7635722</pub-id></mixed-citation></ref><ref id="b36-jpr-3-125"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>EC</given-names></name></person-group><article-title>Food allergies and migraine</article-title><source>Lancet</source><year>1979</year><volume>2</volume><issue>8138</issue><fpage>358</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">89416</pub-id></mixed-citation></ref><ref id="b37-jpr-3-125"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mylek</surname><given-names>D</given-names></name></person-group><article-title>Migraine as one of the symptoms of food allergy</article-title><source>Pol Tyg Lek</source><year>1992</year><volume>47</volume><issue>3&#x02013;4</issue><fpage>89</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">1359512</pub-id></mixed-citation></ref></ref-list></back><floats-group><table-wrap id="t1-jpr-3-125" position="float"><label>Table 1</label><caption><p>IHS criteria for the diagnosis of migraine</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Migraine without aura</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Migraine with aura</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="alpha-upper"><list-item><p>5 attacks fulfilling criteria B &#x02013; D, and not attributed to another disorder</p></list-item><list-item><p>Attacks lasting 4&#x02013;72 hours (untreated or unsuccessfully treated)</p></list-item><list-item><p>Headache has &#x02265;2 of the following characteristics:
<list list-type="simple"><list-item><p>C<sub>1</sub> Unilateral location</p></list-item><list-item><p>C<sub>2</sub> Pulsating quality</p></list-item><list-item><p>C<sub>3</sub> Moderate or severe intensity (inhibits or prohibits daily activities)</p></list-item><list-item><p>C<sub>4</sub> Aggravation by, or causing avoidance of, routine physical activity</p></list-item></list></p></list-item><list-item><p>During headache &#x02265;1 of the following:
<list list-type="simple"><list-item><p>D<sub>1</sub> Nausea and/or vomiting</p></list-item><list-item><p>D<sub>2</sub> Photophobia and phonophobia</p></list-item></list></p></list-item></list></td><td align="left" valign="top" rowspan="1" colspan="1"><list list-type="alpha-upper"><list-item><p>2 attacks fulfilling criteria B and C and not attributed to another disorder</p></list-item><list-item><p>Aura consisting of &#x02265;1 of the following fully reversible symptoms but no motor weakness:
<list list-type="simple"><list-item><p>B<sub>1</sub> Visual symptoms (flickering lights, spots/lines, and/or loss of vision)</p></list-item><list-item><p>B<sub>2</sub> Sensory symptoms (ie, &#x0201c;pins and needles&#x0201d; and/or numbness)</p></list-item><list-item><p>B<sub>3</sub> Dysphasic speech disturbance</p></list-item></list></p></list-item><list-item><p>&#x02265;2 of the following:
<list list-type="simple"><list-item><p>C<sub>1</sub> Homonymous visual symptoms and/or unilateral sensory symptoms</p></list-item><list-item><p>C<sub>2</sub> Aura develops gradually over &#x02265;5 min and/or different aura symptoms occur in succession over &#x02265;5 min</p></list-item><list-item><p>C<sub>3</sub> Each symptom lasts &#x02265;5 min and &#x02264;60 min</p></list-item></list></p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="tfn1-jpr-3-125"><p>Adapted from Cephalalgia.<xref ref-type="bibr" rid="b8-jpr-3-125">8</xref></p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-jpr-3-125" position="float"><label>Table 2</label><caption><p>Dietary list used for the patients in our algology clinic</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Foods to avoid/limit</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Alternatives</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Beverages</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cola</td><td align="left" valign="top" rowspan="1" colspan="1">Non-cola soft drinks</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coffee</td><td align="left" valign="top" rowspan="1" colspan="1">No more than 1 cup</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tea</td><td align="left" valign="top" rowspan="1" colspan="1">No more than 2 cups</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chocolate drinks or cocoa</td><td align="left" valign="top" rowspan="1" colspan="1">Non-chocolate drinks</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcoholic beverages, red wine in particular</td><td align="left" valign="top" rowspan="1" colspan="1">Vodka, Sauterne or Riesling wines</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fruit juices, decaffeinated drinks, flavored waters should be preferred</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Dairy products</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Milk</td><td align="left" valign="top" rowspan="1" colspan="1">Low-fat or skim milk</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Buttermilk and cream</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cream</td><td align="left" valign="top" rowspan="1" colspan="1">Butter/margarine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cheddar, Brie, processed cheeses, aged cheeses (Parmesan, Romano), fats, lard</td><td align="left" valign="top" rowspan="1" colspan="1">Vegetable oils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Meats/poultry/seafood</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ham, bacon, offal &#x02013; chicken livers</td><td align="left" valign="top" rowspan="1" colspan="1">Fresh and non-processed meats</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aged, cured, canned, or marinated meats &#x02013; pepperoni, salami</td><td align="left" valign="top" rowspan="1" colspan="1">Eggs when limited to no more than 3 per week</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Salted, smoked, and dried fish</td><td align="left" valign="top" rowspan="1" colspan="1">Fresh or frozen fish, canned tuna or salmon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Processed meats &#x02013; hot dogs, bologna</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pickled herring</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Vegetables</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Certain navy beans, pinto beans, pole beans, lentils, garbanzo beans, broad beans</td><td align="left" valign="top" rowspan="1" colspan="1">String beans</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Most peas</td><td align="left" valign="top" rowspan="1" colspan="1">Onion when used only for flavoring</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sauerkraut, olives, and pickles</td><td align="left" valign="top" rowspan="1" colspan="1">Asparagus, beets, carrots, spinach, tomatoes, squash, corn, zucchini, broccoli, lettuce, potatoes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Grains, breads, cereals</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Yeast breads &#x02013; most white breads</td><td align="left" valign="top" rowspan="1" colspan="1">Whole wheat, rye, English muffins, Melba toast, bagels</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Doughnuts</td><td align="left" valign="top" rowspan="1" colspan="1">Most cereals</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sourdough</td><td align="left" valign="top" rowspan="1" colspan="1">Rice, pasta</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Crackers with cheese and pastries containing chocolate or nuts</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Soups</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Canned soups</td><td align="left" valign="top" rowspan="1" colspan="1">Soups without MSG or yeast</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Soup cubes and bouillon cubes with MSG</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Fruits</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Figs, raisins, plums, papaya, pineapple, avocados, kiwifruit</td><td align="left" valign="top" rowspan="1" colspan="1">Apples, prunes, cherries, grapes, apricots, peaches, pears</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Citrus fruits, bananas</td><td align="left" valign="top" rowspan="1" colspan="1">Limit citrus fruits and bananas to 1/2 to 1 serving per day</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Desserts/snack foods</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chocolate, ice cream</td><td align="left" valign="top" rowspan="2" colspan="1">Fruits as above, sherbets, ices, sorbets cakes/cookies made without yeast</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cookies and cakes made with yeast</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Potato chip products</td><td align="left" valign="top" rowspan="1" colspan="1">Pretzels</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nuts/seeds, puddings</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Additives</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MSG</td><td align="left" valign="top" rowspan="1" colspan="1">Wine vinegar</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Seasonings and spices</td><td align="left" valign="top" rowspan="1" colspan="1">Limited use of soy sauce</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Artificial sweeteners</td><td align="left" valign="top" rowspan="1" colspan="1">Small amounts of salad dressing</td></tr></tbody></table></table-wrap><table-wrap id="t3-jpr-3-125" position="float"><label>Table 3</label><caption><p>Demographic values of the patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Group</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Age (Year)</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Sex (M/W)</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Height (cm)</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Weight (kg)</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Type<xref ref-type="table-fn" rid="tfn2-jpr-3-125">*</xref> of migraine (1/2)</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Group K</td><td align="left" valign="top" rowspan="1" colspan="1">44.61 &#x000b1; 12.39</td><td align="left" valign="top" rowspan="1" colspan="1">5/20</td><td align="left" valign="top" rowspan="1" colspan="1">165.79 &#x000b1; 7.15</td><td align="left" valign="top" rowspan="1" colspan="1">72.49 &#x000b1; 12.43</td><td align="left" valign="top" rowspan="1" colspan="1">8/17</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Group D</td><td align="left" valign="top" rowspan="1" colspan="1">42.02 &#x000b1; 10.15</td><td align="left" valign="top" rowspan="1" colspan="1">8/17</td><td align="left" valign="top" rowspan="1" colspan="1">167.35 &#x000b1; 9.72</td><td align="left" valign="top" rowspan="1" colspan="1">77.41 &#x000b1; 14.85</td><td align="left" valign="top" rowspan="1" colspan="1">10/15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> values</td><td align="left" valign="top" rowspan="1" colspan="1">0.87</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.86</td><td align="left" valign="top" rowspan="1" colspan="1">0.44</td><td align="left" valign="top" rowspan="1" colspan="1">&#x0003e;0.05</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-jpr-3-125"><label>*</label><p>Type 1, migraine without aura; Type 2, migraine with aura.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-jpr-3-125" position="float"><label>Table 4</label><caption><p>Monthly VAS, number of attacks and analgesic consumption rates of the patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Group</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Monthly VAS</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Monthly number of attacks</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Monthly analgesic consumption</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Group K</td><td align="left" valign="top" rowspan="1" colspan="1">0.88 &#x000b1; 0.53</td><td align="left" valign="top" rowspan="1" colspan="1">5.15 &#x000b1; 1.33</td><td align="left" valign="top" rowspan="1" colspan="1">3.64 &#x000b1; 0.76</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Group D</td><td align="left" valign="top" rowspan="1" colspan="1">0.44 &#x000b1; 0.51</td><td align="left" valign="top" rowspan="1" colspan="1">2.70 &#x000b1; 1.59</td><td align="left" valign="top" rowspan="1" colspan="1">1.88 &#x000b1; 0.78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><italic>P</italic> values</td><td align="left" valign="top" rowspan="1" colspan="1">0.006</td><td align="left" valign="top" rowspan="1" colspan="1">0.007</td><td align="left" valign="top" rowspan="1" colspan="1">0.003</td></tr></tbody></table></table-wrap><table-wrap id="t5-jpr-3-125" position="float"><label>Table 5</label><caption><p>Dietary items and chemical migraine triggers<xref ref-type="bibr" rid="b7-jpr-3-125">7</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Food item</bold></th><th align="left" valign="top" rowspan="1" colspan="1"><bold>Chemical trigger</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Cheese</td><td align="left" valign="top" rowspan="1" colspan="1">Tyramine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chocolate</td><td align="left" valign="top" rowspan="1" colspan="1">Phenylethylamine, theobromine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Citrus fruits</td><td align="left" valign="top" rowspan="1" colspan="1">Phenolic amines, octopamine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hot-dogs, ham, cured meats</td><td align="left" valign="top" rowspan="1" colspan="1">Nitrites, nitric oxide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dairy products, yogurt</td><td align="left" valign="top" rowspan="1" colspan="1">Allergenic proteins (casein, etc)<xref ref-type="table-fn" rid="tfn3-jpr-3-125">a</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fatty and fried foods</td><td align="left" valign="top" rowspan="1" colspan="1">Linoleic and oleic fatty acids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Asian, frozen, snack foods</td><td align="left" valign="top" rowspan="1" colspan="1">Monosodium glutamate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Coffee, tea, cola</td><td align="left" valign="top" rowspan="1" colspan="1">Caffeine, caffeine withdrawal</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Food dyes, additives</td><td align="left" valign="top" rowspan="1" colspan="1">Tartrazine, sulfites</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Artificial sweetener</td><td align="left" valign="top" rowspan="1" colspan="1">Aspartame</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Wine, beer</td><td align="left" valign="top" rowspan="1" colspan="1">Histamine, tyramine, sulfites</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fasting</td><td align="left" valign="top" rowspan="1" colspan="1">Stress hormone release, hypoglycemia</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-jpr-3-125"><label>a</label><p>Ice cream headache is probably a cold-induced vasoconstrictor reflex response.</p></fn></table-wrap-foot></table-wrap></floats-group></article>